Pay in 4 interest-free payments of $5.42 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
It was showed that NP4 treatment leaded to an increase in pro-inflammatory M1-type macrophages and a decrease in anti-inflammatory M2-type macrophages in mouse tumor tissues, with the proportion of M1 to M2 macrophages being 4.4 times higher compared to untreated mouse tumor tissues (Fig
Can create a thicker product consistency Stabilizes the product formulation A polyhydroxy acid (PHA) that helps shed the dead cells from the skin surface revealing smoother skin
Toll-like receptors as a therapeutic target in the era of immunotherapies
Cell 161 , 14371452 (2015)
A 6-month, double-blinded, placebo-controlled trial for DPN patients demonstrated that oral ALA (600 mg twice daily) significantly improved neurological symptom scores (NSS), neurological disability scores (NDS), VAS, and VPT compared to placebo
US$ 27.25
US$ 20.56
US$ 22.97
US$ 29.27
US$ 25.62
